Certara stock.
Certara Inc Stock Price History. Certara Inc’s price is currently up 18.87% so far this month. During the month of November, Certara Inc’s stock price has reached a high of $14.58 and a low of $11.81. Over the last year, Certara Inc has hit prices as high as $24.96 and as low as $11.81. Year to date, Certara Inc’s stock is down 49.01%.
Certara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.Dec 1, 2023 · The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share. Certara stock has received a consensus rating of buy. The average rating score is and is based on 20 buy ratings, 10 hold ratings, and 0 sell ratings. What was the 52-week low for Certara stock?
At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.
PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...
Certara share price went down by -16.68% last month. The next quarterly earnings date for Certara is scheduled on November 7, 2023. Certara's next ex-dividend date is August 20, 2023.Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today ...Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 5 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick exercised 8,646 units of CERT stock worth $181,307 on 31 March 2023.8,646 units of CERT stock worth $181,307 on 31 March 2023.
Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.
Nov 24, 2023 · Bank of Montreal Can purchased a new stake in shares of Certara, Inc. (NASDAQ:CERT – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,490 shares of the company’s stock, valued at approximately $194,000. A number of other hedge funds and other institutional […]
Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensNov 11, 2022 · Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ... Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.The latest price target for . Certara (NASDAQ: CERT) was reported by Stephens & Co. on April 12, 2023.The analyst firm set a price target for $28.00 expecting CERT to rise to within 12 months (a ...Share WA. Call · Chat WA · Facebook Twitter Youtube. Tanyakan tentang properti ini. Halo, saya tertarik dengan [RUMAH Cluster Certara Park Citra Raya – Cikupa].Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...
When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Real time Certara (CERT) stock price quote, stock graph, news & analysis.John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.. The largest trade John's ever made was exercising 5,746 units of Certara stock …13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.13 Sep 2023 ... On the day of the insider's recent sell, shares of Certara Inc were trading for $14.6 apiece, giving the company a market cap of $2.296 billion.Certara Inc Follow Share $14.64 After Hours: $14.64 (0.00%) 0.00 Closed: Dec 1, 4:03:07 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Exscientia PLC $6.17 EXAI1.15% Amazon.com Inc... PRINCETON, N.J.—September 3, 2021. Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and ...
Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.
Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...Sifting through countless of stocks in the Software industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Certara Inc because you’re not sure how they measure up, it’s important to compare them ...New metrics and analytics capabilities enable informed decision making for biopharmaceutical clientsPRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader ...The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …Oct 4, 2021 · At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA. Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ...
7 Nov 2022 ... Certara shares soar after Arsenal buys back EQT's stake · Arsenal says it will acquire roughly 30 million shares at $15 per share, reflecting a ...
Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
4 Apr 2023 ... Certara (CERT), a developer of biosimulation software for drug discovery, dropped Tuesday after Barclays downgraded on valuation concerns.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Conversely, Certara earned 10 cents a share on a non-GAAP basis. Its revenue grew by 14.6% Y/Y to $84.7 million. CERT stock bottomed at $10.60 and closed at $17.72. Certara reiterated its guidance ...Certara recently reported its Q4 2022 financial results, beating revenue and EPS consensus estimates. Read more to know why I rate CERT stock as a hold.1.90%. $360.63M. Adtran Networks SE. 0.50%. €1.02B. CIEN | Complete Ciena Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …The estimated Net Worth of William F Feehery is at least $68.6 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $35,387,994 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...
Certara, Inc. (CERT) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year ...Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …Certara Inc. (NASDAQ:NASDAQ:CERT) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations...View the latest Corteva Inc. (CTVA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Instagram:https://instagram. sagafalabelawhere to buy penny stocksalbemarle corporation stockbill tracker app free Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the … vanguard target retirement 2035 fundbest real estate reit Certara stock drops after biotech software company misses profit target. Certara Inc. CERT, -2.56% stock was down 14.6% in premarket trades on Thursday … american bond fund of america a Aug 12, 2022 · Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ... Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensCertara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...